The structural profiles are close, with Exact Sciences carrying a narrow edge on growth. The remaining gap is narrow enough that the comparison remains open to different readings. On the market side, Exact Sciences is in better shape — its trend is intact while BioMarin Pharmaceutical's trend has broken down. That puts structure and market broadly in agreement — Exact Sciences's lead looks more confirmed than conflicted.
The comparison is based on similar long-term financial trajectories, not sector labels. Both peer scores are relative to the Russell 1000 universe, making them directly comparable.
Growth still does most of the heavy lifting in this comparison.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
This level of similarity points to a meaningful structural match, though not a tight one.
The strongest overlap appears in revenue growth trajectory and margin trend.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The clearest separation appears in growth.
Left means cheaper relative valuation. Higher means stronger structure.
The setup remains mixed because the stronger profile and the more supportive price setup do not sit on the same side.
Valuation position uses peer-relative PE percentile (idx_pct_pe) and Forward P/E where available.
Where BMRN and EXAS each sit in their own 4.9-year price and valuation history.
Describes historical entry positioning only. Descriptive — not investment advice.
Revenue growth reinforces the category-level growth lead.
Absolute pricing still looks more supportive for BioMarin Pharmaceutical, with a forward P/E that is 47 turns lower there.
Growth is the clearest driver, and stability also supports Exact Sciences Corp's broader structural position.
Break down the BMRN vs EXAS comparison across all dimensions with the full interactive tool.
Explore how BMRN and EXAS each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.